Catalyst Wire Dossier Catalyst Wire Dossier

Elezanumab

elezanumab · AbbVie
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Elezanumab, covering 2023-12-21 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI) [Phase 2]

See pricing